Clinical Trial Update: Minimization of IntraLipid Versus Omegaven [Phase 2, Phase 3]

View source ↗

Summary

The document reports Phase 2 and Phase 3 clinical trials comparing Intralipid versus Omegaven for cholestasis and parenteral nutrition-associated liver disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis
• Parenteral Nutrition Associated Liver Disease

Drugs mentioned

• Intralipid (intravenous lipid emulsion)
• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: Children's & Women's Health Centre of British Columbia | Conditions: Cholestasis, Parenteral Nutrition Associated Liver Disease (PNALD) | Phase 2, Phase 3 | Status: UNKNOWN